More Than You Think: The Hidden Burden of Severe Hypoglycemia in T1D - CME - Guideline Central

CME

Title
More Than You Think: The Hidden Burden of Severe Hypoglycemia in T1D
Link
Description
Severe hypoglycemia happens more often than you think—even in patients with well‑controlled type 1 diabetes. This dynamic, case‑based program uses interactive branching scenarios to mirror real clinical decisions, equipping endocrinologists and the broader endocrine care team to spot hidden risks, improve clinician–patient communication, and close persistent gaps in reporting and detection. Walk away ready to apply advanced treatment and technology strategies while implementing a streamlined practice workflow that includes structured screening, risk stratification, targeted patient education, and timely insulin adjustments.
Target Audience
The primary target audience for this educational program is US-based endocrinologists and the endocrine care team, including PAs, nurses, and NPs, who diagnose and treat patients with T1D in their clinical practice settings
Learning Objectives
  • Assess patient risk for severe hypoglycemia by incorporating structured screening questions and validated tools during routine clinical visits.
  • Differentiate between available glucagon formulations to guide appropriate prescribing and improve emergency preparedness.
  • Evaluate the limitations of CGM and automated insulin delivery (AID) systems in patients with impaired awareness of hypoglycemia to inform individualized treatment adjustments.
  • Apply guideline-supported, evidence-based practices to revise insulin therapy and glycemic targets following Level 2 and Level 3 hypoglycemic events.
  • Identify disparities in severe hypoglycemia (SH)-related care to guide equitable access to diabetes technology, SH treatment options, and diabetes education in at-risk populations.
Estimated Duration
120 minutes
Delivery Mode
Online
Format
Online Learning
Specialties
Endocrinology, Primary Care
Keywords
Type 1 Diabetes, hypoglycemia, type 1 diabetes mellitus
Disclosures and Disclaimers
The American Association of Clinical Endocrinology presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The American Association of Clinical Endocrinology and the commercial supporter(s) assume no liability for the information herein.
Accredited Providers
  • American College of Endocrinology (ACE)
Commercial Support
  • Vertex Pharmaceuticals
  • Xeris Pharmaceuticals, Inc
Activity Expiration Date
April 14, 2027
Credit Information
Credit TypeUnits / Unit TypeBoard
AMA PRA Category 1 Credit2 CreditsACCME- Accreditation Council for Continuing Medical Education
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.